These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26559252)

  • 1. Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases.
    Marzano AV; Tavecchio S; Berti E; Gelmetti C; Cugno M
    Medicine (Baltimore); 2015 Nov; 94(45):e1818. PubMed ID: 26559252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation.
    Marzano AV; Tavecchio S; Berti E; Gelmetti C; Cugno M
    Medicine (Baltimore); 2015 Dec; 94(50):e2301. PubMed ID: 26683967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab-induced amicrobial pustulosis of the folds in a patient with Crohn disease.
    Meyer SN; Myers B; Caro-Chang LA; Tartar DM; Wu P; Kiuru M; Toussi A
    Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses.
    Marzano AV; Cugno M; Trevisan V; Lazzari R; Fanoni D; Berti E; Crosti C
    Int J Immunopathol Pharmacol; 2011; 24(2):451-60. PubMed ID: 21658319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Tumor Necrosis Factor-α-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients.
    Andrade P; Lopes S; Gaspar R; Nunes A; Magina S; Macedo G
    Dig Dis Sci; 2018 Mar; 63(3):746-754. PubMed ID: 29349693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.
    Stoffel E; Maier H; Riedl E; Brüggen MC; Reininger B; Schaschinger M; Bangert C; Guenova E; Stingl G; Brunner PM
    Br J Dermatol; 2018 May; 178(5):1151-1162. PubMed ID: 29143979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigmented lichenoid drug eruption: a new clinical presentation of interface dermatitis induced by anti-TNF alpha drugs.
    Darrigade AS; Goussot JF; Milpied B; Taieb A; Seneschal J
    Eur J Dermatol; 2016 Dec; 26(6):633-634. PubMed ID: 27634463
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.
    Włodarczyk M; Sobolewska A; Wójcik B; Loga K; Fichna J; Wiśniewska-Jarosińska M
    World J Gastroenterol; 2014 Jun; 20(22):7019-26. PubMed ID: 24944497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Manifestations in Pediatric Patients Treated With a TNF-Alpha Inhibitor for Inflammatory Bowel Disease: A Retrospective Study [Formula: see text].
    Cossio ML; Genois A; Jantchou P; Hatami A; Deslandres C; McCuaig C
    J Cutan Med Surg; 2020; 24(4):333-339. PubMed ID: 32527153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amicrobial pustulosis-like rash in a patient with Crohn's disease under anti-TNF-alpha blocker.
    Lee HY; Pelivani N; Beltraminelli H; Hegyi I; Yawalkar N; Borradori L
    Dermatology; 2011; 222(4):304-10. PubMed ID: 21757882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amicrobial pustulosis of the folds: Where have we gone 25years after its original description?
    Schissler C; Velter C; Lipsker D
    Ann Dermatol Venereol; 2017 Mar; 144(3):169-175. PubMed ID: 28242094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of literature on amicrobial pustulosis of the folds associated with autoimmune disorders.
    Boms S; Gambichler T
    Am J Clin Dermatol; 2006; 7(6):369-74. PubMed ID: 17173471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
    Weizman AV; Sharma R; Afzal NM; Xu W; Walsh S; Stempak JM; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
    Dig Dis Sci; 2018 Sep; 63(9):2430-2438. PubMed ID: 29736839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amicrobial pustulosis of the folds: A case report of a rare variant of neutrophilic dermatosis associated with systemic lupus erythematosus.
    Varano AT; McKinley TD; Junkins-Hopkins JM
    J Cutan Pathol; 2024 Jan; 51(1):45-49. PubMed ID: 37646439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients.
    Peer FC; Miller A; Pavli P; Subramaniam K
    Intern Med J; 2017 Dec; 47(12):1445-1448. PubMed ID: 29224199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
    J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists.
    Hawryluk EB; Linskey KR; Duncan LM; Nazarian RM
    J Cutan Pathol; 2012 May; 39(5):481-92. PubMed ID: 22515220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical Psoriasiform Eruptions in Children Receiving Tumor Necrosis Factor α Inhibitors.
    Eickstaedt J; Paller AS; Lund E; Murphrey M; Brandling-Bennett H; Maurano M; Fernandez Faith E; Holland KE; Ibler E; Liang MG; Todd PS; Siegfried E; Igelman S; Cordoro KM; Tollefson MM
    JAMA Dermatol; 2023 Jun; 159(6):637-642. PubMed ID: 37043214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists.
    Deubelbeiss C; Kolios AGA; Anzengruber F; French LE; Yawalkar N; Kempf W; Kerl K; Meier B; Navarini AA
    J Cutan Pathol; 2018 Jan; 45(1):23-28. PubMed ID: 29023827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.